Pure Global

"Serpso" erythrocyte low osmotic ionic strength addition solution - Taiwan Registration ab45bd22af97dd23f8fa829ee13d7d20

Access comprehensive regulatory information for "Serpso" erythrocyte low osmotic ionic strength addition solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number ab45bd22af97dd23f8fa829ee13d7d20 and manufactured by CSL LIMITED. The authorized representative in Taiwan is GIRAFFES PHARMACEUTICAL COMPANY LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
ab45bd22af97dd23f8fa829ee13d7d20
Registration Details
Taiwan FDA Registration: ab45bd22af97dd23f8fa829ee13d7d20
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Serpso" erythrocyte low osmotic ionic strength addition solution
TW: โ€œๅกž็ˆพๆ™ฎ็ดขโ€็ด…่ก€็ƒไฝŽๆปฒ้€้›ขๅญๅผทๅบฆๆทปๅŠ ๆถฒ
Risk Class 1
Cancelled

Registration Details

ab45bd22af97dd23f8fa829ee13d7d20

DHA04400947405

Company Information

Australia

Product Details

Limited to the scope of first-level identification of the Measures for the Administration of Medical Devices (B.).

B Hematology, pathology, and genetics

B.9600 Intensive medium for in vitro diagnostics

import

Dates and Status

Nov 05, 2010

Nov 05, 2015

Apr 25, 2018

Cancellation Information

Logged out

่‡ช่กŒ้ตๅ…ฅ